CELL MEDICINE INC has a total of 33 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, environmental technology and biotechnology are SELECTA BIOSCIENCES INC, QU BIOLOG INC and ATRIVA THERAPEUTICS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | Japan | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Canada | 2 | |
#8 | China | 2 | |
#9 | Taiwan | 2 | |
#10 | Brazil | 1 | |
#11 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Ohno Tadao | 21 |
#2 | Uchimura Eiji | 16 |
#3 | Riordan Neil | 7 |
#4 | Ono Tadao | 3 |
#5 | Muragaki Yoshihiro | 2 |
#6 | Nitta Masayuki | 2 |
#7 | Maruyama Takashi | 2 |
#8 | Kuang Ming | 1 |
#9 | Eiji Uchimura | 1 |
#10 | Yamazaki Junji | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020255314A1 | Tumor vaccine | |
US2019136192A1 | Mesenchymal stem cell therapy for spinal muscular atrophy | |
WO2019083995A1 | Mesenchymal stem cell therapy of leigh syndrome | |
CN109689094A | Immunostimulant | |
AU2017235446A1 | Mesenchymal stem cells with enhanced efficacy | |
JP2009084292A | Immunoadjuvant | |
KR20080083199A | Immune adjuvant | |
WO2007077629A1 | Immune adjuvant | |
JP2005126335A | Calcium phosphate microparticle | |
JP2004321637A | Bag for disposition using closed system | |
TWI312284B | Solidified tissue immunological adjuvant | |
CA2478106A1 | Solidified tissue immunoadjuvant |